Thursday, September 10, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $315.34 -0.28%
MSFT $491.65 -0.47%
GOOGL $330.65 -2.28%
AMZN $252.40 -1.78%
TSLA $367.81 -0.10%
META $653.69 +6.55%
NVDA $223.67 -0.91%
JPM $354.71 +0.34%
BTC $34.59 -0.26%
ETH $23.50 -0.76%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$315.34
▼ 0.28%
MSFT
$491.65
▼ 0.47%
GOOGL
$330.65
▼ 2.28%
AMZN
$252.40
▼ 1.78%
TSLA
$367.81
▼ 0.10%
META
$653.69
▲ 6.55%
NVDA
$223.67
▼ 0.91%
JPM
$354.71
▲ 0.34%

Top Stories

Markets →
The Guardian
CPS says charges relate to alleged sexual misconduct by the actor towards five women between 2007 and 2016The actor and filmmaker Noel Clarke has been ⁠charged ​with six sexual offences, including two of sexual assault, after allegations made by five women.The charges against the former Doctor Who actor involve two counts of sexual assault, three counts of voyeurism and one count of exposure. Continue reading...
general  15h ago
Bloomberg Markets
Mike Wilson, chief investment officer and chief US equity strategist at Morgan Stanley, discusses how markets have “digested” multiple risks through the year and says the firm is rotating instead of reducing their overall exposure to equities. Wilson also warns about concerns in the short term for stocks related to crude product prices. (Source: Bloomberg)
business  15h ago
Science Daily
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
science  15h ago

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free